SCFA in gut health. Kristin Verbeke. On behalf of the Prebiotic Task Force of ILSI Europe
|
|
- Ezra Ramsey
- 5 years ago
- Views:
Transcription
1 SCFA in gut health Kristin Verbeke Translational Research in Gastrointestinal Disorders KU Leuven On behalf of the Prebiotic Task Force of ILSI Europe
2 Acetic acid Major anions in the large intestine Propionic acid Pass information from the diet and microbiota to the host inhibitors of HDAC ligands for GPR receptors Butyric acid
3 Gut health Bischoff S., BMC Medicine 2011; 9:24 3
4 Barrier function Epithelial cells Mucus Immune system antimicrobials Natividad et al. Pharmacological Research 2013; 69:
5 SCFA affect tight junctions Natividad et al. Pharmacological Research 2013; 69: Feldman et al. Advanced Drug Delivery Reviews 2005; 57:
6 SCFA affect tight junctions Peng et al. J Nutr 2009;139:
7 Butyrate stabilizes HIF-1 Kelly et al. Cell host & microbe 2015; 17:
8 SCFA stimulate proglucagon-derived peptide 2 (GLP-2) occludin ZO-1 jejunum colon antagonist agonist Cani et al. Gut 2009; 58:
9 Barrier function Epithelial cells Mucus Immune system antimicrobials Natividad et al. Pharmacological Research 2013; 69:
10 SCFA affect mucus production Stimulation of MUC2 gene expression Inhibition of histone deacetylation Synthesis of PGE1 Ex vivo stimulation of mucus production in human biopsies In vivo (humanised rats): increased mucin production In vivo (humans): no effect on MUC2 expression in HS (n=16) and UC patients (n=35) in remission after butyrate enemas (60 ml, 100 mm butyrate) for 2 wks Finnie et al. Gut. 1995;36(1):93-9. Van den Abbeele et al. Environm microbiol 2011 ;13: Hamer et al. Eur J Gastroenterol & hepatol 2010; 22:
11 SCFA affect mucus quality human intestinal epithelial goblet cells treated with 2 mm butyrate microarrays carrying cdna specific for 252 enzymes involved in glycosylation Confirmation with PCR upregulation of galectin-1 gene (LGALS1) expression Gaudier et al. Biochem biophys res comm 2004; 325:
12 Barrier function Epithelial cells Mucus Immune system antimicrobials Natividad et al. Pharmacological Research 2013; 69:
13 SCFA affect MAPK and NF-ĸB pathway Li et al. Eur J Pharmacol 2018; 831:
14 Involvement of the inflammasome pathway Macia et al. Nat Commun 2015; 6:
15 SCFA mediate colonic T reg Directly by interaction with T cells SCFA exposure ameliorates colitis in a T cell transfer model of colitis SCFA restore colonic T reg populations and function in germfree mice Smith et al. Science 2013;341: SCFA augment colonic T reg populations and function in SPFmice 15
16 SCFA mediate colonic T reg Via modulation of DC function DC exposed to butyrate increases the expression of IDO and Aldh 1A2 DC exposed to butyrate promote conversion to a tolerogenic phenotype in T-cells Gurav et al. Biochem J 2015; 469: DC exposed to butyrate suppress conversion into pro-inflammatory IFN-γ + T-cells 16
17 SCFA stimulate siga production Wildtype mice GPR43 -/- mice GPR43 -/- mice have lower faecal IgA and less IgA+ B-cells in their lamina propria Supplementation with acetate increased faecal IgA and IgA+ cells only in WT mice expression of Aldh1a2 was increased in acetate-treated DC acetate induction of RA expression enhances B cell IgA production RA treatment promoted B cell IgA production Wu et al. Mucosal immunology. 2017; 10:
18 Efficacy of SCFA in treatment of ulcerative colitis n Enema treatment Results Reference mm butyrate and placebo 100 ml, ph=7, b.d. for stool frequency, blood discharge, Scheppach wks. Wash out: 2wks endoscopic & histological scores 45 CS, 5 ASA or 130 mm SCFA (46:23:31*) 60 ml, ph=7, SCFAs equally efficacious to CS or 5 ASA Senagore 1992 b.d. for 6wks mm SCFA (53:20:27) vs. placebo 100 ml b.d. for SCFAs intestinal bleeding, urgency and Vernia wks patient self evaluation score mm SCFA (46:23:31) vs. 100 mm butyrate vs. No differences between groups. Scheppach 1996 Placebo 60 ml, ph=5.5, b.d. for 4 8 wks Butyrate for 8 wks fewer colonic segments affected endoscopically mm butyrate vs. placebo 60 ml, ph=7 for 6 wks No differences between butyrate and placebo Steinhart 1996 treatment mm SCFA (53:20:27) vs. placebo 100 ml, ph=7 no therapeutic value Breuer 1997 b.d. for 6 wks mm SCFA (46:23:31) vs. 100 mm butyrate vs. Placebo 60 ml, ph=5.5, b.d. for 4 8 wks Butyrate trend for reduced density of neutrophils in lamina propria. SCFA and butyrate cell proliferation in upper crypt Scheppach mm butyrate vs. placebo 60 ml, ph=5.5, b.d. for 4 8 wks Butyrate number of nuclear translocated NF κb positive macrophages, number of neutrophils and Disease Activity Index Luhrs ASA and saline vs. 5 ASA and 80 mm butyrate 80 ml b.d. for 6wks 5 ASA in combination with butyrate more patients into remission, bowel movements, urgency and patient s self evaluation Vernia 2003 Hamer et al. Aliment Pharmacol & Ther 2008; 27:
19 Barrier function Epithelial cells Mucus Immune system antimicrobials Natividad et al. Pharmacological Research 2013; 69:
20 Butyrate stimulates cathelicidin-ll37 HCA-7 cells HT-29 cells Hase et al. Infection and immunity 2002; 70: Schauber et al. Immunology 2006; 118:
21 Motility and transit: animal models Propionate and butyrate but not acetate induce contraction of colonic muscle ex vivo in rats Effects of SCFA are dose-dependent Effects of SCFA might differ between species Potential mechanisms: Secretion of PYY Interaction with GPR41 and GPR43 Stimulation of 5-HT release Saline 100 mm SCFA 500 mm SCFA Tazoe et al. J Physiol Pharmacol. 2008;59 Suppl 2: Mitsui et al. Neurogastroenterol Motil 2005; 17: Fukumoto et al. Am J Physiol Regul Integr Comp Physiol 2003; 284:R Cherbut et al. Am J Physiol 1998; 275: G
22 Motility and transit: humans Jouet et al. Neurogastroenterol Motil 2013; 25:
23 Calcium absorption: mechanisms luminal ph Ca-complexation Upregulation of proteins involved in paracellular Cauptake Transcription of TRP6 transcellular Ca-uptake Upregulation of calbindin-d9k Presence of Ca-H exchanger in distal colon Kashimura et al. Biol Trace Elem Res 1996; 54: Fukushima et al. J Nutr 2009; 139:20-5. Fukushima et al. J Nutr Sci Vitaminol 2012; 58: Lutz T, Scharrer E. Exp Physiol 1991; 76:
24 Calcium absorption Healthy subjects (n=6) Rectal infusions (300 ml) of 50 mm CaCl 2 56,3 mm acetate or 18.7 mm propionate or both Ca absorption linearly related to Ca concentration in the presence and absence of Ac and Pr, involves a non-saturable diffusion process Ca absorption is increased by Ac and Pr, and Ac and Pr absorption are stimulated by Ca. Trinidad et al. Nutrition Research. 1993;13: Trinidad et al. Am J Clin Nutr 1996;63: Trinidad et al. Adv Exp Med Biol 1997;427: Trinidad et al. Nutrition. 1999;15:
25 Calcium absorption p=0.04 Abrams et al. Am J Clin Nutr 2005; 82:
26 Conclusions In vitro and animal experiments provide compelling evidence for a role of SCFA in the improvement of gut barrier function although not completely resolved, molecular mechanisms have been studied extensively and in great detail In humans, it remains difficult to demonstrate improved barrier due to SCFA No studies directely assessed the impact of SCFA intervention on barrier function in humans Mixed results from studies that modulate the microbiota and presumably SCFA production Most studies did not measure SCFA or only measured faecal SCFA Assays that measure barrier function in vivo (most often permeability tests) suffer from considerable variability and might be not sensitive enough 26
27 Conclusions (II) At physiological concentrations, SCFA seem not to affect colonic motility in humans SCFA not only increase intestinal absorption of calcium but also result in higher bone mineral content and density. 27
28 28
Studies on probiotics effects on innate immune functions in the gastrointestinal tract of broiler chicks (SUMMARY)
Doctoral Thesis Studies on probiotics effects on innate immune functions in the gastrointestinal tract of broiler chicks (SUMMARY) ELSAYED SEDDEK IBRAHEM MOHAMMED Department of Bioresource Science Graduate
More informationDiverticular Disease: Looking beyond fiber
Binghamton University The Open Repository @ Binghamton (The ORB) Health & Wellness Studies Faculty Scholarship Decker School of Nursing Fall 10-28-2015 Diverticular Disease: Looking beyond fiber Lina Begdache
More informationHOW THE MICROBIOME AFFECTS OUR HEALTH
HOW THE MICROBIOME AFFECTS OUR HEALTH THE INTESTINAL BARRIER AND INTESTINAL PERMEABILITY Intestinal Barrier: a functional body Defense from translocation of dietary antigens, bacteria or bacterial endotoxins
More informationSlide 1. Slide 2 Learning outcomes. Slide 3. Year 1 MBChB Lecture 15 Introduction to the Gut Microbiota. The importance of microbiota
Slide 1 Year 1 MBChB Lecture 15 Introduction to the Gut Microbiota Professor Barry Campbell Gastroenterology Research Unit Cellular & Molecular Physiology, Institute of Translational Medicine bjcampbl@liv.ac.uk
More informationNecrotizing Enterocolitis: The Role of the Immune System
Necrotizing Enterocolitis: The Role of the Immune System Patricia Denning, M.D. Associate Professor in Pediatrics Division of Neonatology Emory University School of Medicine What is NEC? What is NEC? Necrotizing
More informationHealth Benefits of Prebiotic Dietary Fiber
Health Benefits of Prebiotic Dietary Fiber JENNIFER ERICKSON, PhD, RD Objectives Provide some background on dietary fiber To define the term "prebiotic dietary fiber" To discuss potential health effects
More informationTowards Microbial Fermentation Metabolites as Biomarkers for Health Benefits of Prebiotics"
Towards Microbial Fermentation Metabolites as Biomarkers for Health Benefits of Prebiotics" Kieran Tuohy for working group on Microbial Metabolism and Fermentation SUPPORTED BY THE ILSI EUROPE PREBIOTICS
More informationMicrobiome GI Disorders
Microbiome GI Disorders Prof. Ram Dickman Neurogastroenterology Unit Rabin Medical Center Israel 1 Key Points Our gut microbiota Were to find them? Symbiosis or Why do we need them? Dysbiosis or when things
More informationButyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells.
Chem Biol Interact. 2010 May 14;185(3):174-81. Epub 2010 Mar 25. Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Zhang Y, Zhou L, Bao YL, Wu
More informationFaecalibacterium prausnitzii
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients PNAS 105(43): 16731-16736, 2008. Speaker: Ming-Cheng Chen Advisor:
More informationIntestinal Microbiota in Health and Disease
Intestinal Microbiota in Health and Disease February 27, 2015 Master s Course in Gastroenterology Prof. Kathy McCoy 1 Overview Overview of Gut Microbiota Microbiota in Health Microbiota in Disease 2 Gut
More informationInnate Immunity in the Intestine
Master s course in biomedical sciences Innate Immunity in the Intestine Dr. Kathy McCoy February 26 th, 2013 1 Host-Microbial Homeostasis: Innate Immunity Pharynx & upper respiratory tract ~1010 - Barriers
More informationThe Microbiome, Cancer and Cachexia
Oslo, January 18, 2018 The Microbiome, Cancer and Cachexia Prof. Laure Bindels, PhD Dzutsev et al, Annu Rev Immunol 2017 Outline o Introduction to the gut microbiota o Gut microbiota-host crosstalk in
More informationWhat is the evidence that dietary components can act on the microbiome and influence health?
What is the evidence that dietary components can act on the microbiome and influence health? Kristin Verbeke Translational Research in Gastrointestinal Disorders KU Leuven, Leuven, Belgium Diet? health
More informationGenetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD
Advances in the Pathogenesis of IBD: Genetics Leads to Function Pathogenesis of IBD Environmental Factors Microbes Scott Plevy, MD Associate Professor of Medicine, Microbiology & Immunology UNC School
More informationProbiotic bacteria: mechanisms of action?
Probiotic bacteria: mechanisms of action? Probiotic derived antibacterial substances (microcins) Competitive inhibition of pathogens Modulation of inflammatory responses: Increasing antiinflammatory cytokine
More informationParenteral Nutrition. Outline. Potential Biomarkers for Use in Intestinal Adaptation. Jejunum is primary site of digestion and absorption
Outline Potential Biomarkers for Use in Intestinal Adaptation Kelly A. Tappenden, Ph.D., R.D. Professor of Nutrition and GI Physiology 1. Intestinal Adaptation potential regulators 2. Intestinal mucosal
More informationBringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute
Bringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute Jennifer T. Smilowitz, PhD Associate Director, Human Studies Research jensm@ucdavis.edu
More informationShort Chain Fatty Acids and Poultry Gut Health Vanessa Iseri, PhD Kemin Industries, Inc.
Short Chain Fatty Acids and Poultry Gut Health Vanessa Iseri, PhD Kemin Industries, Inc. Email: Vanessa.Iseri@kemin.com Introduction Due to customer demands, producers have been asked to change the way
More informationFaecal Calprotectin. Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS)
Faecal Calprotectin Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS) Reliable, Non Invasive Identification of IBD vs IBS Available from Eurofins
More informationROLE OF THE GUT BACTERIA
ROLE OF THE GUT BACTERIA Our Good Bacteria In a perfect world, we would all have a proper ratio of good bacteria And what could this proper ratio do for us? The knowledge of the connections between our
More informationDifferential responses of human colonic ILCs to gut commensal bacteria altered during HIV infection
Differential responses of human colonic ILCs to gut commensal bacteria altered during HIV infection Moriah J. Castleman, Ph.D. Laboratory of Dr. Cara Wilson University of Colorado Anschutz Medical Campus
More informationClinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut
Clinically proven to quickly relieve symptoms of common gastrointestinal disorders GASTROINTESTINAL DISEASE Referred to as gastrointestinal diseases, they are common disorders which affect the esophagus,
More informationGrup de fisiologia digestiva i adaptacions nutricionals Institut de Nutrició i Seguretat Alimentaria
Grup de fisiologia digestiva i adaptacions nutricionals Institut de Nutrició i Seguretat Alimentaria 1 Outline Weaning and the consequences of stress Animal blood plasma Spray-drying SDP SDP in a model
More informationMucosal healing: does it really matter?
Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does it really matter? Professor Jean-Frédéric Colombel, New York, USA Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does
More informationMurine Models of. Inflammatory Bowel Disease. Outline. Laura P. Hale, M.D. Ph.D. Professor of Pathology Duke University Medical Center
Murine Models of Inflammatory Bowel Disease Laura P. Hale, M.D. Ph.D. Professor of Pathology Duke University Medical Center September 19, 2017 Outline Review of IBD in humans Murine models of IBD Tissue
More informationPrevention and Therapy of Antibiotic Associated Diarrhea (ADD) through Probiotics
Prevention and Therapy of Antibiotic Associated Diarrhea (ADD) through Probiotics DGMIM, 15.-16.10.2010 16.10.2010 Stuttgart Prof. Rémy Meier, MD GI-Department University Hospital Liestal, Switzerland
More informationXV Jornada de Avances en Hepatología Málaga 20 y 21 de Mayo de Barrera intestinal en la cirrosis. Agustín Albillos
XV Jornada de Avances en Hepatología Málaga 20 y 21 de Mayo de 2016 Barrera intestinal en la cirrosis Agustín Albillos Hospital Universitario Ramón y Cajal Universidad de Alcalá, Ciberehd Madrid, Spain
More informationHistological and immunological characteristics of colitis associated with anti-ctla 4 antibody therapy
Histological and immunological characteristics of colitis associated with anti-ctla 4 antibody therapy M. Perdiki 2, G. Bamias 1, D. Pouloudi 2, H. Gogas 3, I. Delladetsima 2 1 Academic Dpt. of Gastroenterology,
More informationDysbiosis & Inflammation
MASTERING THE MICROBIOME: Dysbiosis & Inflammation 2017 Tom Fabian, PhD It is reasonable to propose that the composition of the microbiome and its activities are involved in most, if not all, of the biological
More informationDietary Fiber and its Influence on Gut Health
Dietary Fiber and its Influence on Gut Health Dietary Fiber and its Influence on Gut Health It is well known that dietary fiber plays a significant role in preventing non-communicable diseases such as
More informationulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236
Subject Index Actin cellular forms 48, 49 epidermal growth factor, cytoskeletal change induction in mucosal repair 22, 23 wound repair 64, 65 polyamine effects on cytoskeleton 49 51 S-Adenosylmethionine
More informationDiabetes and the Microbiome Structure, Function, and Terminology
Diabetes and the Microbiome Structure, Function, and Terminology Kim L. Kelly, PharmD, BCPS, FCCP, CDTC, CPC, CEC Kelly Diabetes Associates, LLC Cupertino, CA Patricia Davidson, DCN, RDN, CDE, LDN, FAND
More informationLECTURE 12: MUCOSAL IMMUNITY GUT STRUCTURE
LECTURE 12: MUCOSAL IMMUNITY GUT STRUCTURE - Small intestine in humans is around 3-4 metres long - Internal surface of the small intestines are lined by villi o Villi are composed of absorptive cells (epithelial/enterocytes)
More informationReviewers' comments: Reviewer #1 (Remarks to the Author):
Reviewers' comments: Reviewer #1 (Remarks to the Author): The manuscript by Sun et al., provide data showing that short-chain fatty acids produced by intestinal microbiota act through GPR43 to induced
More informationTHE ROLE OF INTESTINAL EPITHELIAL CELLS AND THE REGULATION OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR IN HOMEOSTASIS AND INFLAMMATION
University of Kentucky UKnowledge Theses and Dissertations--Microbiology, Immunology, and Molecular Genetics Microbiology, Immunology, and Molecular Genetics 2012 THE ROLE OF INTESTINAL EPITHELIAL CELLS
More informationThe role of gut microbiome in IBS
The role of gut microbiome in IBS Chung Owyang, MD H. Marvin Pollard Professor of Internal Medicine Professor of Molecular and Integrative Physiology Chief, Division of Gastroenterology Director, Pollard
More informationGut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI
Gut Microbiota and IBD Vahedi. H M.D Associate Professor of Medicine DDRI 1393.3.1 2 GUT MICROBIOTA 100 Trillion Microbes - 10 times more than cells in our body Collective weight of about 1kg in human
More informationUnlocking the mysteries of gut comfort
Priority Research Programme Foods for improving gut function and comfort Unlocking the mysteries of gut comfort Nicole Roy, Professor AgResearch and Riddet Institute Host institution Foods for gut function
More informationSeries Editors: Daniel Kamin, MD and Christine Waasdorp Hurtado, MD
NASPGHAN Physiology Lecture Series GI Physiology Module: Absorption of Water and Ions Jason Soden, MD Reviewers: George Fuchs MD: UAMS College of Medicine / Arkansas Children s Hospital Wayne Lencer MD:
More informationD2 inhibits TLR2- initiated 12p40 transcription (-) TLR2 PGN MDP. MyD88 IRAK ECSIT TRAF6 NIK. Smallest unit of PGN muramyl dipeptide IKK.
D2 inhibits TLR2- initiated 12p40 transcription CARD CARD NOD2 LRR RICK/Rip2 NIK MDP TRAF6 PGN TLR2 MyD88 IRAK ECSIT (-) IKK Smallest unit of PGN muramyl dipeptide IκB NF-κB atanabe et al, 2004 NF-κB IL-12p40
More information17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012
17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012 The Sagamore Resort, Bolton Landing, NY, USA The following report includes highlights
More informationSUMMARY Coeliac disease is a common food intolerance in Western populations, in which it has a prevalence of about 1%. In early infancy, when the transition is made to a gluten-containing diet (particularly
More informationInnate immune regulation of T-helper (Th) cell homeostasis in the intestine
Innate immune regulation of T-helper (Th) cell homeostasis in the intestine Masayuki Fukata, MD, Ph.D. Research Scientist II Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation,
More informationEver wonder what s really happening on the inside?
For Practitioners Ever wonder what s really happening on the inside? Are your patients suffering from diarrhea, constipation, bloating, gas or indigestion? Rocky Mountain Analytical is now offering Gut-Well
More informationAsthma. In Europe ~30 million children and adults under 45 have asthma. On average 3 people a day die from asthma in the UK
Dr Neil Williams Nottingham Trent University College of Science and Technology Department of Sport Science Email: neil.williams@ntu.ac.uk @NeilW_ExPhys 1 Asthma In Europe ~30 million children and adults
More informationShort Bowel Syndrome: Medical management
Short Bowel Syndrome: Medical management La Sindrome dell'intestino Corto in età pediatrica Brescia 18 marzo 2011 Jon A.Vanderhoof, M.D. Division of Pediatric GI Harvard Medical School Children s Hospital,
More informationExosomes as a. Novel Therapeutic Approach to Gastrointestinal Diseases Rebecca Murray APRN, FNP, CDE
Exosomes as a Novel Therapeutic Approach to Gastrointestinal Diseases Rebecca Murray APRN, FNP, CDE Endocrine Nurse Practitioner Institute for Hormonal Balance Orlando, FL Medical Director Ward-Murray
More informationAlexander Shikhman MD, PhD Institute for Specialized Medicine July 20, 2013
Alexander Shikhman MD, PhD Institute for Specialized Medicine July 20, 2013 SPONDYLOARTHROPATHIES The spondyloarthropathy family consists of the following entities: Ankylosing spondylitis Undifferentiated
More informationBUTYRATE PRODUCING BACTERIA AS PROBIOTIC TREATMENT IN IBD
INTERNATIONAL SYMPOSIUM ON IBD RESEARCH FUNDED BY PATIENTS' ORGANISATIONS BUTYRATE PRODUCING BACTERIA AS PROBIOTIC TREATMENT IN IBD Annelies Geirnaert Laboratory of Microbial Ecology and Technology (LabMET),
More informationFecal microbiota transplantation: The When,the How and the Don t. By Dr Rola Hussein
Fecal microbiota transplantation: The When,the How and the Don t By Dr Rola Hussein Introduction Fecal microbiota transplantation (FMT) involves administration of fecal material containing distal gut microbiota
More informationA gut health approach to metabolic health.
Medicine, Nursing and Health Sciences A gut health approach to metabolic health. Dr Jane Muir Head of Translational Nutrition Science Department of Gastroenterology, Central Clinical School RAPIDLY CONVERGING
More informationIntestinal Barrier Dysfunction: The Primary Driver of IBD?
2 Intestinal Barrier Dysfunction: The Primary Driver of IBD? Pieter Hindryckx and Debby Laukens Ghent University Belgium 1. Introduction The healthy gastrointestinal tract is functionally maintained by
More informationIntestinal epithelial vitamin D receptor signaling inhibits experimental colitis
Research article Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis Weicheng Liu, 1 Yunzi Chen, 1,2 Maya Aharoni Golan, 1 Maria L. Annunziata, 1 Jie Du, 2 Urszula Dougherty,
More informationSignal Transduction in Inflammatory Bowel Disease
E v e n t s 0 6 4 Signal Transduction in Inflammatory Bowel Disease 0 1 2 3 4 1 0 1 0 1 0 1 0 1 0 F L 2 - H e ig h t Vineeta Khare Ph.D Overview Inflammatory Bowel Diseases 1. Epidemiology, Symptoms and
More informationA Case of Inflammatory Bowel Disease
A Case of Inflammatory Bowel Disease Dr Barrie Rathbone www.le.ac.uk 26 year old Polish woman Admitted as emergency under surgeons RUQ and RIF pain Abdominal pain had occurred intermittently for a few
More informationAVX-470, an Orally Delivered Anti-TNF Antibody for Treatment of Acute Ulcerative Colitis: Results of a First-in- Human Trial
AVX-470, an Orally Delivered Anti-TNF Antibody for Treatment of Acute Ulcerative Colitis: Results of a First-in- Human Trial M Scott Harris 1, Deborah Hartman 1, Sharon Spence 1, Sally Kennedy 1, Theodore
More informationIl microbiota intestinale: come regola la riserva e la spesa energetica? Gerardo Nardone.
Il microbiota intestinale: come regola la riserva e la spesa energetica? Gerardo Nardone nardone@unina.it Department of Medicine and Surgery Gastroenterology Unit University Federico II, of Naples, Italy
More informationEfficacy and Safety of Treatment for Pediatric IBD
Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Assistant Professor of Clinical Pediatrics Division of Gastroenterology,
More informationINTESTINAL DISEASE MEETING BERLIN Topical steroids rectal application
INTESTINAL DISEASE MEETING BERLIN 2006 Topical steroids rectal application Prof. Dr. med. T. Andus Department of Internal Medicine, Gastroenterology, Hepatology, and Oncology Krankenhaus Bad Cannstatt,
More informationExploring the link between gut microbiota and metabolic health
Food Matters Live, Nov 21-23 rd, London Exploring the link between gut microbiota and metabolic health Ellen Blaak Professor in Physiology of fat metabolism, Department of Human Biology NUTRIM School of
More informationMucosal Immunology Sophomore Dental and Optometry Microbiology Section I: Immunology. Robin Lorenz
Mucosal Immunology Sophomore Dental and Optometry Microbiology Section I: Immunology Robin Lorenz rlorenz@uab.edu Why do we Need to Understand How the Mucosal Immune System Works? The mucosa is the major
More informationEscherichia coli Nissle 1917
Immunoregulation in Inflammatory Bowel Diseases New therapeutic approaches Probiotics Escherichia coli Nissle 1917 Andreas Sturm Medizinische Klinik m.s. Hepatologie, Gastroenterologie, Endokrinologie
More informationEfficacy and Safety of Treatment for Pediatric IBD
Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Associate Professor of Clinical Pediatrics Division of Gastroenterology,
More informationMolecular and Cellular Basis of Immune Protection of Mucosal Surfaces
Molecular and Cellular Basis of Immune Protection of Mucosal Surfaces Department of Biologic & Materials Sciences School of Dentistry University of Michigan Ann Arbor, Michigan 48109-1078 1 Image quality
More informationOnce Daily Dosing for Induction and Maintenance of Remission in Ulcerative Colitis
Once Daily Dosing for Induction and Maintenance of Remission in Ulcerative Colitis John K. Marshall MD MSc FRCPC AGAF Division of Gastroenterology McMaster University JKM 2014 Svartz N. Acta Med Scand
More informationA Conceptual Framework for Defining Mechanisms of Probiotic Action
A Conceptual Framework for Defining Mechanisms of Probiotic Action Prof. Sarah Lebeer UAntwerpen (BE) ILSI Session - How Do Prebiotics and Probiotics Work? Mechanistic Insights Into Their Function Probiotics
More informationFERRING PHARMACEUTICALS. Enjoy The simple COR/939/2014/CH3
Enjoy The simple pleasures of life COR/939/2014/CH3 Ulcerative colitis disrupts the simple pleasures in life Patients with ulcerative colitis may live with a considerable symptom burden despite medical
More informationModulation of abdominal pain by probiotics. Anna Lyra, PhD DuPont Nutrition & Health
Modulation of abdominal pain by probiotics Anna Lyra, PhD DuPont Nutrition & Health Functional gastrointestinal (GI) wellbeing Up to 70% suffer from functional GI symptoms - ¾ do not seek medical care
More informationSAM PROVIDER TOOLKIT
THE AMERICAN BOARD OF PATHOLOGY Maintenance of Certification (MOC) Program SAM PROVIDER TOOLKIT Developing Self-Assessment Modules (SAMs) www.abpath.org The American Board of Pathology (ABP) approves educational
More informationOutline. Epidemiology of Pediatric HIV 10/3/2012. I have no financial relationships with any commercial entity to disclose
Nutritional, Metabolic, and Gastrointestinal Complications in Pediatric HIV Infection Tracie L. Miller, MD Department of Pediatrics University of Miami, Miller School of Medicine I have no financial relationships
More informationPositioning Biologics in Ulcerative Colitis
Positioning Biologics in Ulcerative Colitis Bruce E. Sands, MD, MS Acting Chief, Gastrointestinal Unit Massachusetts General Hospital Associate Professor of Medicine Harvard Medical School Sequential Therapies
More informationPatho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology
Patho Basic Chronic Inflammatory Bowel Diseases Jürg Vosbeck Pathology General Group of chronic relapsing diseases with chronic bloody or watery diarrhea Usually ulcerative colitis (UC) or Crohn s disease
More informationMild-moderate Ulcerative Colitis Sequential & Combined treatments need to be tested. Philippe Marteau, Paris, France
Mild-moderate Ulcerative Colitis Sequential & Combined treatments need to be tested Philippe Marteau, Paris, France Sequential vs combined treatments When should one switch? Sequential vs combined treatments
More informationCannabis finds its way into treatment of Crohn s disease
Europe PMC Funders Group Author Manuscript Published in final edited form as: Pharmacology. 2014 ; 93(0): 1 3. doi:10.1159/000356512. Cannabis finds its way into treatment of Crohn s disease Rudolf Schicho
More informationAminosalicylates. Giovanni Barbara. Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Italy ( )
Aminosalicylates Giovanni Barbara Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Italy (1088 2016) Colonic Diverticula, a Painless Ageing Change? 20% develop symptoms
More informationWhat Have We Learned About the Microbiome in Pediatric IBD?
What Have We Learned About the Microbiome in Pediatric IBD? Ted Denson, MD Cincinnati Children s Hospital Medical Center and the University of Cincinnati College of Medicine Disclosures: NIH, CCF, AbbVie
More informationThe two different types of fibers are soluble and insoluble fibers
FIBER FACTS Fiber is the indigestible remnants of plant cells found in fruits, vegetables, whole grains, nuts, seeds, and beans, act through the digestive tract. It cannot be digested by enzymes present
More informationINFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic
INFLAMMATORY BOWEL DISEASE Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic WHAT IS INFLAMMATORY BOWEL DISEASE (IBD)? Chronic inflammation of the intestinal tract Two related
More informationMucosal immunity Reddy April Deveshni Reddy Allergy Meeting 13 April 2012
Deveshni Reddy Allergy Meeting 13 April First recorded by Hippocrates over 2000 years ago. 1921: Prausnitz and Kustner demonstrated that substance responsible for Kustner s fish allergy was present in
More informationUnlocking the mysteries of gut comfort
Priority Research Programme Foods for improving gut function and comfort Unlocking the mysteries of gut comfort Nicole Roy, Professor AgResearch and Riddet Institute Host institution Foods for gut function
More informationCROHN S DISEASE AND ULCERATIVE COLITIS
Slide 1 CROHN S DISEASE AND ULCERATIVE COLITIS Slide 2 Slide 3 Crohn s Inflammation in the GI tract but usually in the lower part of the small intestines and the colon. Inflammation occur between healthy
More informationExploration of the microbiota in inflammatory diseases. Matthew Stoll MD Research Computing Day September 13, 2012
Exploration of the microbiota in inflammatory diseases Matthew Stoll MD Research Computing Day September 13, 2012 We re surrounded by bugs Human body contains 100 trillion microbes Out-number human cells
More informationWhat do we need for diagnosis of IBD
What do we need for diagnosis of IBD Kaichun Wu Dept. of Gastroenterology, Xijing Hospital Fourth Military Medical University Xi an an,, China In China UC 11.6/10 5,CD 1.4/10 5 Major cause of chronic diarrhea
More information12/10/2009. Department of Pathology, Case Western Reserve University. Mucosal Cytokine Network in IBD
Cytokine-Mediated Inflammation in IBD Theresa T. Pizarro Department of Pathology, Case Western Reserve University Mucosal Cytokine Network in IBD Andoh, et al., 2008 1 Interleukin-1 (IL-1) Family Cytokine
More informationESPEN Congress Vienna Networking with your microbiota Specific evidence-based indications. H. Lochs (Germany)
ESPEN Congress Vienna 2009 Networking with your microbiota Specific evidence-based indications H. Lochs (Germany) Probiotics Evidence based indications H. Lochs Medizinische Klinik mit Schwerpunkt Gastroenterologie,
More informationAccepted Manuscript. Innate immune cells regulate oncoimmunity and cancer development. Ai-Ping Bai, Yuan Guo
Accepted Manuscript Innate immune cells regulate oncoimmunity and cancer development Ai-Ping Bai, Yuan Guo PII: S0016-5085(18)34974-6 DOI: 10.1053/j.gastro.2018.08.057 Reference: YGAST 62119 To appear
More informationAli Keshavarzian MD Rush University Medical Center, Chicago, IL
Ali Keshavarzian MD Rush University Medical Center, Chicago, IL Ulcerative colitis Crohn s disease Optimize Quality of Life Induce remission [treat flare up] Maintain remission [avoid flare up] Prevent
More informationINTRODUCING YOUR GUT BACTERIA
INTRODUCING YOUR GUT BACTERIA Microflora Intestinal flora 1.5 kg We would die with 5 years of birth if we did not have them as we would not develop a proper immune system 1000 species and 5000 strains
More informationResearch Update: Looking for the Answers
Research Update: Looking for the Answers Ted Denson, M.D. Schubert-Martin Inflammatory Bowel Disease Center Research Support: NIH/NIDDK, CCFA, BMRP Figure 2 Approach to Improve Outcomes for our IBD Patients
More informationPutting it Together. Stephen Canfield Secondary Lymphoid System. Tonsil Anterior Cervical LN s
Putting it Together Stephen Canfield smc12@columbia.edu Secondary Lymphoid System Tonsil Anterior Cervical LN s Axillary LN s Mediastinal/Retroperitoneal LN s Thoracic Duct Appendix Spleen Inguinal LN
More informationThe Role of MicroRNAs in NEC Misty Good, MD
The Role of MicroRNAs in NEC Misty Good, MD Neonatologist, Assistant Professor of Pediatrics Division of Newborn Medicine, Children s Hospital of Pittsburgh Department of Pediatrics, University of Pittsburgh
More informationReview article: induction therapy for patients with active ulcerative colitis
Alimentary Pharmacology & Therapeutics Review article: induction therapy for patients with active ulcerative colitis S. P. L. TRAVIS John Radcliffe Hospital and Linacre College, Oxford, UK Correspondence
More informationWelke rol speelt het microbioom bij malaborptie? - Microbiome and malabsorption -
Welke rol speelt het microbioom bij malaborptie? - Microbiome and malabsorption - Daisy Jonkers Division Gastroenterology-Hepatology Maastricht University Medical Center+ 20 april 2017 d.jonkers@maastrichtuniversity.nl
More informationDESIGN AND DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM OF 5 FLUORURACIL & METRONIDAZOLE
1. Introduction: DESIGN AND DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM OF 5 FLUORURACIL & METRONIDAZOLE Oral controlled - release formulations for the small intestine and colon have received considerable
More information1. Digestion of foods and absorption of nutrients takes place in stomach and small bowel in only 2-3 h.
1. Digestion of foods and absorption of nutrients takes place in stomach and small bowel in only 2-3 h. 2. The waste is then stored for 2 days in the large bowel. 3. Do modern humans need a large bowel?
More informationMucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium
Mucosal Healing in Crohn s Disease Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium Mucosal Lesions in CD: General Features CD can affect the entire GI tract
More informationSER-287 Phase 1b topline study results in patients with mild-to-moderate Ulcerative Colitis October 2, 2017
SER-287 Phase 1b topline study results in patients with mild-to-moderate Ulcerative Colitis October 2, 2017 Leading the Microbiome Revolution Forward Looking Statements Some of the statements in this presentation
More informationRecent Advances in the Management of Refractory IBD
Recent Advances in the Management of Refractory IBD Raina Shivashankar, M.D. Assistant Professor of Medicine Division of Gastroenterology and Hepatology Thomas Jefferson University Philadelphia, PA Outline
More informationFructo-oligosaccharides in Crohn s disease: a prospective randomised double blind controlled trial
Fructo-oligosaccharides in Crohn s disease: a prospective randomised double blind controlled trial Principal investigator: Dr James Lindsay St Bartholomew's Hospital and The Royal London Hospital Queen
More information